Donor and transplant candidate selection for solid organ transplantation during the COVID-19 pandemic.
Donor and transplant candidate selection for solid organ transplantation during the COVID-19 pandemic.
复制标题
DOI：
10.1111/ajt.16138
复制
发表时间：
2020-11
期刊：
影响因子：
--
通讯作者：
中科院分区：
文献类型：
--
作者：
严重急性呼吸综合征冠状病毒2型（SARS-CoV-2）是一种新型冠状病毒，可导致全球大流行，在惊人的短时间内迫使医疗实践发生巨大变化。护理人员必须修改他们的策略，并优化资源的利用，以确保公众和病人的安全。特别是在器官移植方面，失去用于移植的救命器官可能导致等待名单上的死亡率增加。优先考虑的是选择未受感染的供体移植未受感染的受体，同时在致命的大流行的背景下保持卫生保健系统的安全。我们还没有一个标准的方法来评估可能感染SARS-CoV-2的供体和受体。我们目前的沟通分享了2019年冠状病毒病（COVID-19）大流行期间供体和移植受体选择的协议，以继续为心脏，肺，肝脏和肾脏受体进行挽救生命的实体器官移植。本文介绍了使用该方案的初步结果，旨在鼓励提供者之间的对话，为在有限的卫生保健资源下提高实体器官移植的安全性提供思路。该方案是利用各种组织的指导方针和作者的临床经验创建的，并将随着对SARS-CoV-2及其如何影响器官捐献者和移植受者的更多了解而继续发展。
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), a novel coronavirus responsible for a worldwide pandemic has forced drastic changes in medical practice in an alarmingly short period of time. Caregivers must modify their strategies as well as optimize the utilization of resources to ensure public and patient safety. For organ transplantation, in particular, the loss of lifesaving organs for transplantation could lead to increased waitlist mortality. The priority is to select uninfected donors to transplant uninfected recipients while maintaining safety for health care systems in the backdrop of a virulent pandemic. We do not yet have a standard approach to evaluating donors and recipients with possible SARS-CoV-2 infection. Our current communication shares a protocol for donor and transplant recipient selection during the coronavirus disease 2019 (COVID-19) pandemic to continue lifesaving solid organ transplantation for heart, lung, liver, and kidney recipients. The initial results using this protocol are presented here and meant to encourage dialogue between providers, offering ideas to improve safety in solid organ transplantation with limited health care resources. This protocol was created utilizing the guidelines of various organizations and from the clinical experience of the authors and will continue to evolve as more is understood about SARS-CoV-2 and how it affects organ donors and transplant recipients.
登录
查看更多内容
影响因子：
8.8
作者：
Ritschl, Paul V.;Nevermann, Nora;Pratschke, Johann
通讯作者：
Pratschke, Johann
影响因子：
19.7
作者：
Pan, Feng;Ye, Tianhe;Zheng, Chuansheng
通讯作者：
Zheng, Chuansheng
影响因子：
19.7
作者：
Bernheim, Adam;Mei, Xueyan;Chung, Michael
通讯作者：
Chung, Michael
影响因子：
4.8
作者：
Yoon, Soon Ho;Lee, Kyung Hee;Kim, Yun Hyeon
通讯作者：
Kim, Yun Hyeon
影响因子：
19.7
作者：
Chung, Michael;Bernheim, Adam;Shan, Hong
通讯作者：
Shan, Hong